| scholarly article | Q13442814 |
| P50 | author | Shehzad Basaria | Q44358165 |
| Thiago Gagliano-Jucá | Q47445348 | ||
| Thomas Travison | Q87644876 | ||
| Karol M Pencina | Q91565844 | ||
| P2093 | author name string | Robert R Edwards | |
| Zhuoying Li | |||
| M Furkan Burak | |||
| P2860 | cites work | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
| Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes | Q27703246 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Inflammation and metabolic disorders | Q27860923 | ||
| Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy | Q28258997 | ||
| Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases | Q28744267 | ||
| Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States | Q33926384 | ||
| Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome | Q34227893 | ||
| Adverse effects of androgen deprivation therapy and strategies to mitigate them. | Q34432516 | ||
| Inflammation, metaflammation and immunometabolic disorders | Q34550852 | ||
| Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 | ||
| Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer | Q35022837 | ||
| Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts | Q35137175 | ||
| Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese subjects | Q35179101 | ||
| Acute testosterone deprivation reduces insulin sensitivity in men | Q35573457 | ||
| Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes | Q36392574 | ||
| Endocrine complications of androgen-deprivation therapy in men with prostate cancer. | Q36651421 | ||
| Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study | Q36906939 | ||
| Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis | Q37113079 | ||
| Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production | Q37127299 | ||
| Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth | Q37196025 | ||
| Association between endogenous sex steroid hormones and inflammatory biomarkers in US men | Q37265941 | ||
| Pre-diabetes, metabolic syndrome, and cardiovascular risk | Q37982915 | ||
| Dysfunctional HDL and atherosclerotic cardiovascular disease | Q38577283 | ||
| Low Plasma Testosterone Is Associated With Elevated Cardiovascular Disease Biomarkers | Q38652939 | ||
| Global Burden of Urologic Cancers, 1990-2013. | Q39060012 | ||
| Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts | Q41287831 | ||
| Elevated high sensitivity C-reactive protein levels in aging men with low testosterone | Q43225768 | ||
| Androgen deprivation therapy reversibly increases endothelium-dependent vasodilation in men with prostate cancer | Q43242594 | ||
| Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. | Q44018378 | ||
| Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial | Q44070350 | ||
| Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia | Q44290482 | ||
| The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. | Q44968760 | ||
| Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study | Q46415794 | ||
| Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. | Q46570705 | ||
| Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. | Q46818839 | ||
| Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy | Q46875718 | ||
| Insulin sensitivity during combined androgen blockade for prostate cancer | Q46909972 | ||
| Cancer statistics, 2018. | Q47191906 | ||
| Relationship between twelve adipocytokines and distinct components of the metabolic syndrome | Q47737658 | ||
| Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer | Q47760342 | ||
| Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis | Q49797701 | ||
| Radiotherapy and short-term androgen deprivation for localized prostate cancer. | Q51021354 | ||
| Circulating adipocyte fatty acid-binding protein induces insulin resistance in mice in vivo. | Q51034889 | ||
| TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients. | Q51354485 | ||
| Endogenous sex hormones and C-reactive protein in healthy Chinese men. | Q51361424 | ||
| Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy. | Q51385645 | ||
| Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. | Q51464753 | ||
| Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy. | Q51499900 | ||
| Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. | Q51504291 | ||
| Cardiovascular disease associated with androgen-deprivation therapy: time to give it due respect. | Q53584843 | ||
| Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. | Q53620233 | ||
| Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer. | Q55278779 | ||
| Changes Over Time in Hepatic Markers Predict Changes in Insulin Sensitivity, β-Cell Function, and Glycemia | Q57178360 | ||
| Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men | Q74352559 | ||
| Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease | Q79710937 | ||
| Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer | Q80285083 | ||
| Circulating inflammatory cytokine expression in men with prostate cancer undergoing androgen deprivation therapy | Q83994846 | ||
| Anti-TNF-α therapy improves insulin sensitivity in non-diabetic patients with psoriasis: a 6-month prospective study | Q85888806 | ||
| Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer | Q88412381 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 3900-3908 | |
| P577 | publication date | 2018-10-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Metabolic Changes in Androgen-Deprived Nondiabetic Men With Prostate Cancer Are Not Mediated by Cytokines or aP2 | |
| P478 | volume | 103 |
| Q99608551 | EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer |
| Q57455389 | Mechanisms Responsible for Reduced Erythropoiesis during Androgen Deprivation Therapy in Men with Prostate Cancer |
| Q92256319 | Testosterone replacement therapy and cardiovascular risk |
Search more.